Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models

Affiliations

• ¹ National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Via Turi 27, 70013, Castellana Grotte, Italy.
• ² iOnctura SA, Avenue Secheron 15, 1202, Geneva, Switzerland.
• ³ TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBEREHD ? ISCIII, Barcelona, Spain.
• ⁴ National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Via Turi 27, 70013, Castellana Grotte, Italy. gianluigi.giannelli@irccsdebellis.it.